FAM53C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.89049999491198E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.6987000018307E-08 |
Normal-vs-Stage2 |
2.443800E-04 |
Normal-vs-Stage3 |
5.616100E-03 |
Normal-vs-Stage4 |
5.654100E-02 |
Stage1-vs-Stage2 |
4.006000E-01 |
Stage1-vs-Stage3 |
6.841500E-02 |
Stage1-vs-Stage4 |
1.974580E-01 |
Stage2-vs-Stage3 |
3.731800E-01 |
Stage2-vs-Stage4 |
4.968800E-01 |
Stage3-vs-Stage4 |
9.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.36340000400637E-08 |
Normal-vs-AfricanAmerican |
6.40929999999873E-05 |
Normal-vs-Asian |
2.113000E-01 |
Caucasian-vs-AfricanAmerican |
6.590800E-01 |
Caucasian-vs-Asian |
5.351200E-01 |
AfricanAmerican-vs-Asian |
4.582800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.96299976273906E-10 |
Normal-vs-Female |
2.898600E-03 |
Male-vs-Female |
1.724960E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.188200E-04 |
Normal-vs-Extreme_Weight |
4.50579995536771E-09 |
Normal-vs-Obese |
1.65430000031996E-07 |
Normal-vs-Extreme_Obese |
4.060700E-03 |
Normal_Weight-vs-Extreme_Weight |
2.975800E-01 |
Normal_Weight-vs-Obese |
6.708400E-01 |
Normal_Weight-vs-Extreme_Obese |
9.478600E-01 |
Extreme_Weight-vs-Obese |
3.626200E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.692200E-01 |
Obese-vs-Extreme_Obese |
7.843800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.530590E-01 |
Normal-vs-Age(41-60Yrs) |
7.68800000000569E-05 |
Normal-vs-Age(61-80Yrs) |
2.35750308164029E-11 |
Normal-vs-Age(81-100Yrs) |
8.2867000000042E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.186200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.186400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.440000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.403550E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.386210E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.339400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.71294098297403E-12 |
Normal-VS-Type2 PRCC |
1.178500E-03 |
Normal-VS-KIRP CIMP |
3.781700E-02 |
Normal-VS-Unclassified PRCC |
1.131960E-02 |
Type1 PRCC-VS-Type2 PRCC |
4.644900E-03 |
Type1 PRCC-VS-KIRP CIMP |
4.485700E-02 |
Type1 PRCC-VS-Unclassified PRCC |
9.816700E-03 |
Type2 PRCC-VS-KIRP CIMP |
8.167400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.461400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.505200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.15009999991057E-08 |
Normal-vs-N1 |
2.581600E-01 |
Normal-vs-N2 |
2.041400E-01 |
N0-vs-N1 |
6.000500E-03 |
N0-vs-N2 |
2.866800E-01 |
N1-vs-N2 |
6.095600E-01 |
|
|